Organisation paid for research Program year 2025 Source: CMS Open Payments

Alpesh D Desai DO PLLC

Neither a doctor nor a teaching hospital

Research payments

$108,161

8 payments

Through program year 2025, Alpesh D Desai DO PLLC is reported as receiving $108,161 in research payments, across 8 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$695	1
2024	Research	$2,257	1
2023	Research	$3,129	1
2022	Research	$37,311	3
2021	Research	$64,768	2

Breakdown

Who paid Research payments · program years 2021–2025

Boehringer Ingelheim Pharmaceuticals, Inc. $105,209 6 payments
Pfizer Inc. $2,952 2 payments

Studies the money was for Research payments · program years 2021–2025

BI 730357 Psoriasis Long Term Extension $53,162 1 payment
5 Years OLE Phase II Trial in PPP $32,160 3 payments
BI 730357 PoCC and dose ranging in Psoriasis $11,606 1 payment
Dose finding Trial in PPP Phase II $8,281 1 payment
A Phase 3 Randomized Withdrawal and Doseup Titration Multicenter Extension Study Investigating the Safety Efficacy and Tolerability of Ritlecitinib in Adult and Adolescent Participants With Nonsegmental Vitiligo $2,257 1 payment
A Phase 3 Randomized Doubleblind 52Week Placebocontrolled Multicenter Study Investigating the Efficacy Safety and Tolerability of Ritlecitinib in Adult and Adolescent Participants With Non Segmental Vitiligo $695 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.